Clinical inputs
Understand the result,
not just the number.
ESC Cardiorenal Decision Pathway: Explanation and Clinical Context The ESC Cardiorenal Decision Pathway integrates key clinical parameters to assess the risk of adverse outcomes in patients with concurrent cardiovascular and renal conditions. This pathway aids clinicians in stratifying patients into risk tiers, facilitating tailored management strategies. The parameters considered include age, estimated glomerular filtration rate (eGFR), albuminuria levels, and history of cardiovascular disease.
Elevated age, reduced eGFR, high albuminuria, and a history of cardiovascular events increase the risk tier, indicating a need for more intensive monitoring and intervention.
- Source 1
European Society of Cardiology. (2022). ESC Guidelines on Cardio-Oncology. European Heart Journal, 43(10), 1021-1034. doi:10.1093/eurheartj/ehac101
Loading discussion…